Shariati, Maryam
Evans, Kurt W.
Zheng, Xiaofeng
Bristow, Christopher A.
Ng, Patrick Kwok-Shing
Rizvi, Yasmeen Q.
Tapia, Coya
Yang, Fei
Carugo, Alessandro http://orcid.org/0000-0001-5182-3320
Heffernan, Timothy P.
Peoples, Michael D.
Tripathy, Debu http://orcid.org/0000-0002-5711-2404
Meric-Bernstam, Funda http://orcid.org/0000-0001-6816-6072
Funding for this research was provided by:
UTHealth | Center for Clinical and Translational Sciences, University of Texas Health Science Center at Houston (1UL1TR003167-01)
Cancer Prevention and Research Institute of Texas (RP150535)
U.S. Department of Health & Human Services | NIH | National Cancer Institute (CA-16672)
Nellie B. Connally Breast Cancer Research Endowment; MD Anderson Cancer Center Sheikh Khalifa Bin Zayed Al Nahyan Institute for Personalized Cancer;
Article History
Received: 10 November 2020
Revised: 9 April 2021
Accepted: 23 April 2021
First Online: 9 June 2021
Conflict of interest
: MS, KWE, XZ, CA, PKS Ng, YQR, FY, AC, and MDP declare no potential conflict of interest. CT is an employee of Epizyme Inc., and performed contract work for Armo Bioscience. TPH reports personal fees and stock ownership from Cullgen Inc. DT reports receiving commercial research grants from Novartis, Polyphor. He also served as a consultant for Pfizer, AstraZeneca, GlaxoSmithKline, Genomic Heath, OncoPep. FMB reports receiving commercial research grants from Aileron Therapeutics, Inc. AstraZeneca, Bayer Healthcare Pharmaceutical, Calithera Biosciences Inc., Curis Inc., CytomX Therapeutics Inc., Daiichi Sankyo Co. Ltd., Debiopharm International, eFFECTOR Therapeutics, Genentech Inc., Guardant Health Inc., Klus Pharma, Millennium Pharmaceuticals Inc., Novartis, Puma Biotechnology Inc., and Taiho Pharmaceutical Co. She also served as a consultant for AbbVie, Aduro BioTech Inc., DebioPharm, eFFECTOR Therapeutics, F. Hoffman-La Roche Ltd., Genentech Inc., IBM Watson, Infinity Pharmaceutical, Jackson Laboratory, Kolon Life Science, OrigiMed, PACT Pharma, Parexel International, Pfizer Inc., Samsung Bioepis, Seattle Genetics Inc., Tyra Biosciences, Xencor, and Zymeworks. In addition, she has served on advisory committees for Immunomedics, Inflection Biosciences, Mersana Therapeutics, Puma Biotechnology Inc., Seattle Genetics, Silverback Therapeutics, Spectrum Pharmaceuticals and Zentalis.